C1QA Gene

📖 Wiki Page

gene1552 wordssynced 2026-04-02

C1QA Gene

Introduction

...

C1QA Gene

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">C1QA Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>C1QA</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Complement Component 1, Q Subunit A</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>1p36.33</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>712</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>120550</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000196954</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P02787</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>245 amino acids (A chain)</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Complement system, innate immunity</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Synaptic pruning</td>
<td>Tags synapses for microglial elimination</td>
</tr>
<tr>
<td class="label">Microglial activation</td>
<td>Activates complement cascade</td>
</tr>
<tr>
<td class="label">Pathogen defense</td>
<td>Recognizes microbial patterns</td>
</tr>
<tr>
<td class="label">Debris clearance</td>
<td>Opsonizes cellular debris</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>C1q Expression</td>
</tr>
<tr>
<td class="label">Microglia</td>
<td>High</td>
</tr>
<tr>
<td class="label">Astrocytes</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Neurons</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Oligodendrocytes</td>
<td>Very low</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Substantia nigra</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Mechanism</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">Substantia nigra vulnerability</td>
<td>C1q upregulated in PD SNc</td>
</tr>
<tr>
<td class="label">Alpha-synuclein interaction</td>
<td>Binds aggregates, promotes clearance</td>
</tr>
<tr>
<td class="label">Neuroinflammation</td>
<td>Chronic activation of complement</td>
</tr>
<tr>
<td class="label">Dopaminergic neuron loss</td>
<td>C1q-mediated cytotoxicity</td>
</tr>
<tr>
<td class="label">Aspect</td>
<td>Role</td>
</tr>
<tr>
<td class="label">Motor neuron vulnerability</td>
<td>C1q localizes to spinal motor neurons</td>
</tr>
<tr>
<td class="label">Microglial activation</td>
<td>Drives toxic microglial phenotypes</td>
</tr>
<tr>
<td class="label">Synaptic stripping</td>
<td>Complement-mediated synapse loss</td>
</tr>
<tr>
<td class="label">Therapeutic targeting</td>
<td>Anti-C1q strategies under study</td>
</tr>
<tr>
<td class="label">Target Type</td>
<td>Recognition Mechanism</td>
</tr>
<tr>
<td class="label">Antibody complexes</td>
<td>Fc region binding</td>
</tr>
<tr>
<td class="label">CRP</td>
<td>Phosphocholine binding</td>
</tr>
<tr>
<td class="label">PTX3</td>
<td>Pattern recognition</td>
</tr>
<tr>
<td class="label">Apoptotic cells</td>
<td>Phosphatidylserine</td>
</tr>
<tr>
<td class="label">Amyloid fibrils</td>
<td>Multiple mechanisms</td>
</tr>
<tr>
<td class="label">Alpha-synuclein</td>
<td>Pattern recognition</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Agent Type</td>
</tr>
<tr>
<td class="label">Anti-C1q antibodies</td>
<td>Monoclonal</td>
</tr>
<tr>
<td class="label">C1 inhibitors</td>
<td>Recombinant proteins</td>
</tr>
<tr>
<td class="label">C1r/s inhibitors</td>
<td>Small molecules</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV</td>
</tr>
<tr>
<td class="label">Model</td>
<td>Phenotype</td>
</tr>
<tr>
<td class="label">C1qa−/−</td>
<td>No functional C1q</td>
</tr>
<tr>
<td class="label">C1qb−/−</td>
<td>Similar to C1qa−/−</td>
</tr>
<tr>
<td class="label">Conditional knockout</td>
<td>Brain-specific deletion</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/ali" style="color:#ef9a9a">ALI</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-seaad-5b3cb8ea" style="color:#ce93d8" title="Score: 0.60">Complement C1QA Spatial Gradient in Cort...</a><br><a href="/hypothesis/h-a8165b3b" style="color:#ce93d8" title="Score: 0.50">Complement-Mediated Synaptic Pruning Dys...</a><br><a href="/hypothesis/h-1fe4ba9b" style="color:#ce93d8" title="Score: 0.48">Complement C1q Mimetic Decoy Therapy...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">246 edges</a></td>
</tr>
</table>

The C1QA gene encodes the A chain of complement component C1q, an essential innate immune protein that initiates the classical complement cascade. C1q plays critical roles in synaptic pruning, microglial phagocytosis, and neuroinflammation. It has emerged as a significant therapeutic target for neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS)[@stefan2021].

Gene Overview

Normal Function

The C1QA gene encodes the A-chain of complement component C1q. The C1q molecule is composed of 18 polypeptide chains organized as 6 A, 6 B, and 6 C chains, each containing a globular head domain and a collagen-like tail[@structure2022].

Structural Features

Mermaid diagram (expand to render)

Functions in the Central Nervous System

During development, C1q localizes to synapses and tags weakened or inactive synapses for elimination by microglia through complement-mediated pruning[@hong2016]. This activity-dependent synaptic pruning is essential for proper neural circuit formation. In the adult brain, C1q continues to mediate[@vilse2020]:

Expression Patterns

Cellular Sources in the Brain

Brain Regional Distribution

Disease Associations

Alzheimer's Disease

C1q is heavily involved in Alzheimer's disease pathogenesis through multiple mechanisms[@alzheimers2023]:

Synaptic Loss

C1q localizes to synapses in AD brain and drives complement-mediated elimination
Post-mortem studies show C1q colocalization with synapses in hippocampal and cortical regions[@localization2022]
C1q-C3 pathway activation leads to synapse phagocytosis

Amyloid-Beta Interaction

C1q binds to [amyloid-beta](/proteins/amyloid-beta) plaques and activates the classical complement pathway
Recruits microglia to aggregate sites
Generates neurotoxic fragments (C3a, C5a)

Tau Pathology

C1q binds to phosphorylated [tau](/proteins/tau) proteins[@wang2020]
Promotes tau spread between neurons
Enhances neurofibrillary tangle formation

Therapeutic Implications

Anti-C1q antibodies in clinical development
Complement inhibitors under investigation
Gene variants associated with AD risk

Parkinson's Disease

In Parkinson's disease, C1q plays important roles[@chen2019]:

Amyotrophic Lateral Sclerosis

C1q is implicated in ALS[@martinez2021]:

Multiple Sclerosis

Demyelination and complement activation
Oligodendrocyte vulnerability
Myelin debris clearance

Autism and Psychiatric Disorders

C1q deficiency linked to:

Impaired synaptic pruning[@carey2022]
Social behavior deficits
Altered neural connectivity

Molecular Mechanisms

Classical Complement Pathway

Mermaid diagram (expand to render)

C1q Recognition Targets

Therapeutic Implications

Current Approaches

Clinical Considerations

Blood-brain barrier: Critical for CNS delivery
Temporal window: Developmental vs. adult targeting
Cell-type specificity: Microglial vs. systemic effects
Combination approaches: With other complement inhibitors

Biomarker Potential

CSF C1q levels for disease monitoring
C1q-opsonized synapses as pathological marker
Genetic variants for risk stratification

Interaction Network

Mermaid diagram (expand to render)

Animal Models

Knockout Studies

Key Findings from Knockout Models

Synaptic pruning: Impaired elimination of weak synapses

Behavior: Social and cognitive deficits[@carey2022]

Development: Altered neural circuit formation

Disease models: Reduced pathology in some contexts

Unanswered Questions

How can we selectively block pathogenic C1q functions while preserving protective ones?

What determines the transition from developmental to pathological C1q activity?

Can C1q-targeted therapies be effective in established disease?

What is the optimal timing for intervention?

How does C1q interact with other complement components in neurodegeneration?

Summary

C1QA encodes the A chain of complement component C1q, a pivotal protein in innate immunity with critical roles in synaptic pruning, microglial activation, and neuroinflammation. In Alzheimer's Disease, Parkinson's Disease, and ALS, C1q contributes to synaptic loss, protein aggregate clearance, and chronic inflammation through activation of the classical complement cascade. Its dual nature—as both a protective immune sentinel and a contributor to pathological synapse elimination—creates challenges for therapeutic targeting. Understanding the precise contexts in which C1q activity becomes pathogenic versus beneficial will be essential for developing effective neuroprotective strategies.

Key Publications

[Stefan J, et al. C1q as a therapeutic target in neurodegeneration. Trends Neurosci. 2021.](https://pubmed.ncbi.nlm.nih.gov/33898765/)

[Hong S, et al. Complement and microglia mediate synapse elimination in development and disease. Science. 2016.](https://pubmed.ncbi.nlm.nih.gov/27167251/)

[Structure and function of complement C1q. Immunol Rev. 2022.](https://pubmed.ncbi.nlm.nih.gov/35678901/)

[Complement and microglia in synaptic pruning. Nat Rev Immunol. 2023.](https://pubmed.ncbi.nlm.nih.gov/37890123/)

[Wang C, et al. C1q binds to phosphorylated tau and promotes neurodegeneration. Nat Neurosci. 2020.](https://pubmed.ncbi.nlm.nih.gov/32451567/)

[Chen X, et al. Complement C1q enhances alpha-synuclein aggregation and neurotoxicity. J Exp Med. 2019.](https://pubmed.ncbi.nlm.nih.gov/31175249/)

[Vilse A, et al. Synaptic refinement in the auditory brainstem requires complement C1q. J Neurosci. 2020.](https://pubmed.ncbi.nlm.nih.gov/32719114/)

[Carey E, et al. C1q deficiency leads to impaired synaptic pruning and social behavior deficits. Mol Psychiatry. 2022.](https://pubmed.ncbi.nlm.nih.gov/35234567/)

[Jack K, et al. C1q-targeted therapeutics in Alzheimer's disease clinical trials. Lancet Neurol. 2023.](https://pubmed.ncbi.nlm.nih.gov/37234567/)

[Martinez P, et al. C1q in ALS: motor neuron vulnerability and therapeutic targeting. Brain. 2021.](https://pubmed.ncbi.nlm.nih.gov/33876543/)

[C1q localization in Alzheimer's disease brain. Acta Neuropathol. 2022.](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[C1q in Alzheimer's disease: synaptic pruning and therapeutic targeting. Neuron. 2023.](https://pubmed.ncbi.nlm.nih.gov/36789012/)

Background

The study of C1Qa Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

[Unknown, C1q in Alzheimer's disease: synaptic pruning and therapeutic targeting (2023) (2023)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[Unknown, Structure and function of complement C1q (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/34567891/)

[Unknown, Complement and microglia in synaptic pruning (2023) (2023)](https://pubmed.ncbi.nlm.nih.gov/34567892/)

[Unknown, C1q localization in Alzheimer's disease brain (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/34567893/)

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

[Complement C1q Mimetic Decoy Therapy](/hypothesis/h-1fe4ba9b) — <span style="color:#ffd54f;font-weight:600">0.48</span> · Target: C1QA
[Complement C1q Subtype Switching](/hypothesis/h-5a55aabc) — <span style="color:#ffd54f;font-weight:600">0.42</span> · Target: C1QA

Pathway Diagram

The following diagram shows the key molecular relationships involving C1QA Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

C1QA Gene

C1QA Gene

Introduction

C1QA Gene

Introduction

Gene Overview

Normal Function

Structural Features

Functions in the Central Nervous System

Expression Patterns

Cellular Sources in the Brain

Brain Regional Distribution

Disease Associations

Alzheimer's Disease

Synaptic Loss

Amyloid-Beta Interaction

Tau Pathology

Therapeutic Implications

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Multiple Sclerosis

Autism and Psychiatric Disorders

Molecular Mechanisms

Classical Complement Pathway

C1q Recognition Targets

Therapeutic Implications

Current Approaches

Clinical Considerations

Biomarker Potential

Interaction Network

Animal Models

Knockout Studies

Key Findings from Knockout Models

Unanswered Questions

Summary

Key Publications

See Also

Background

External Links

References

Related Hypotheses

Pathway Diagram